Hypoxia in human prostate carcinoma: an Eppendorf PO2 study

Area of Science:

• Oncology
• Medical Physics
• Biomedical Engineering

Background:

• Prostate carcinoma is a significant health concern.
• Tumor hypoxia is increasingly recognized as a factor influencing cancer progression and treatment resistance.
• Understanding oxygen levels in prostate tumors is crucial for developing effective therapies.

Purpose of the Study:

• To characterize the extent of hypoxia in human prostate carcinoma.
• To compare oxygen levels in cancerous prostate tissue versus normal muscle tissue.
• To identify predictors of tumor oxygenation.

Main Methods:

• Utilized custom-made Eppendorf PO2 microelectrodes for in vivo oxygen measurements.
• Measured PO2 in pathologically involved prostate regions and adjacent normal muscle in 59 localized prostate cancer patients.
• Performed multivariate mixed effects analysis including various clinical and pathological covariates.

Main Results:

• Significantly lower oxygen levels were observed in prostate tumors (average median PO2 = 2.4 mm Hg) compared to normal muscle (average median PO2 = 30.0 mm Hg) (p < 0.0001).
• Multivariate analysis revealed that the type of tissue (prostate vs. muscle) was the only significant predictor of oxygenation.
• No other tested covariates (PSA, stage, age, race, grade, volume, perineural invasion, hormonal therapy) predicted tumor oxygenation.

Conclusions:

• In vivo electrode measurements confirm the presence of hypoxia in human prostate carcinoma.
• Tissue type is the primary determinant of oxygen levels in this context.
• Further patient accrual is planned to correlate tumor oxygenation with treatment outcomes.